Stock Chart

MEDP

$599.47 +0.23%
Score: 37.7 AVOID NEW MONEY
LEAPs: SELL $620
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $620
Premium: $119.59
Expiry: Aug 20, 2027
Target: $616
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 1.28x (vs SPY: 1.3x | vs QQQ: 1.2x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 02, 2026
Rising Channel weak / forming — below our quality gate quality 49/100
A Rising Channel is taking shape but hasn't passed our quality gate (60/100), so no projected path or levels are shown — only the forming rails on the chart below.
Lower rail breaks first 80% of the time (n=1,744) — a trend-exit tell, not a crash call
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About MEDP - Medpace Holdings, Inc. Common Stock

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. …

Key Statistics

Market Cap $17B
P/E Ratio 35.10

This MEDP stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track MEDP's price movements with trendlines, gamma walls, and key support/resistance levels.